Association of Polygenic Risk Score With Blood Pressure and Adverse Cardiovascular Outcomes in Individuals With Type II Diabetes: Insights From the ACCORD Trial

Hypertension. 2022 May;79(5):e100-e102. doi: 10.1161/HYPERTENSIONAHA.122.18976. Epub 2022 Apr 4.

Authors

Vibhu Parcha¹, Akhil Pampana¹, Adam P Bress², Marguerite R Irvin³, Garima Arora¹, Pankaj Arora^{1

4}

Affiliations

¹ Division of Cardiovascular Disease (V.P., A.P., G.A., P.A.).
² Department of Population Health Sciences, University of Utah School of Medicine, Salt Lake City (A.B.).
³ Department of Epidemiology, School of Public Health (M.R.I.), University of Alabama at Birmingham.
⁴ Section of Cardiology, Birmingham Veterans Affairs Medical Center, AL (P.A.).

No abstract available

Keywords: blood pressure; cardiovascular disease; diabetes mellitus; genomics; genotype; hypertension.

Publication types

Letter

MeSH terms

Antihypertensive Agents / pharmacology
Antihypertensive Agents / therapeutic use
Blood Pressure
Cardiovascular Diseases* / etiology
Cardiovascular Diseases* / genetics
Clinical Trials as Topic
Diabetes Mellitus, Type 2* / complications
Diabetes Mellitus, Type 2* / drug therapy
Diabetes Mellitus, Type 2* / genetics
Humans
Hypertension* / drug therapy
Hypertension* / genetics
Risk Factors

Substances

Antihypertensive Agents

Grants and funding